| Titolo |
Pubblicato in |
Anno |
| Neuropathic pain experience in symptomatic and presymptomatic subjects carrying a transthyretin gene mutation |
FRONTIERS IN NEUROLOGY |
2023 |
| Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy |
JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY |
2023 |
| Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies |
EUROPEAN JOURNAL OF NEUROLOGY |
2023 |
| Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study |
LANCET NEUROLOGY |
2023 |
| Real-life experience with inotersen in hereditary transthyretin amyloidosis with late-onset phenotype: Data from an early- access program in Italy |
EUROPEAN JOURNAL OF NEUROLOGY |
2022 |
| Functional and morphometric assessment of small-fibre damage in late-onset hereditary transthyretin amyloidosis with polyneuropathy: the controversial relation between small-fibre-related symptoms and diagnostic test findings |
AMYLOID |
2022 |
| Muscle MRI in immune-mediated necrotizing myopathy (IMNM). implications for clinical management and treatment strategies |
JOURNAL OF NEUROLOGY |
2022 |
| Distal upper limb involvement in myasthenia-myositis association |
NEUROLOGICAL SCIENCES |
2022 |
| Nerve high-resolution ultrasound in a 2-years follow-up of radial nerve palsy related to humeral shaft fractures |
JOURNAL OF NEUROSURGICAL SCIENCES |
2022 |
| Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score |
NEUROLOGY |
2022 |
| Benefit and danger from immunotherapy in myasthenia gravis |
NEUROLOGICAL SCIENCES |
2021 |
| Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up |
JOURNAL OF NEUROLOGY |
2021 |
| A 5-year clinical follow-up study from the Italian National Registry for FSHD |
JOURNAL OF NEUROLOGY |
2021 |
| Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension |
NEUROLOGY |
2021 |
| Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy |
ORPHANET JOURNAL OF RARE DISEASES |
2021 |
| ATTRv in Lazio-Italy: A High-Prevalence Region in a Non-Endemic Country |
GENES |
2021 |
| The neurophysiological lesson from the Italian CIDP database |
NEUROLOGICAL SCIENCES |
2021 |
| Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP |
JOURNAL OF NEUROLOGY |
2021 |
| Skin biopsy and quantitative sensory assessment in an Italian cohort of ATTRv patients with polyneuropathy and asymptomatic carriers: possible evidence of early non-length dependent denervation |
NEUROLOGICAL SCIENCES |
2021 |
| Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT). a multicentre, randomised, placebo-controlled, phase 3 trial |
LANCET NEUROLOGY |
2021 |
